Ecolab (ECL, $161.85) beats Q4 earnings expectations; analysts raise price targets
Ecolab posted fourth-quarter FY22 adjusted earnings per share of $1.27, which surpassed analysts’ expectations of $1.25. Sales grew +9.1% year-on-year to $3.67 billion, vs. consensus of $3.70 billion.
For Q1 FY23, Ecolab expects adjusted earnings per share of $0.82-$0.90, compared to analysts’ forecast of $0.85.
Following their quarterly results, Ecolab shares got price target hikes from some analysts. RBC Capital increased the price target to $185 from $155, while RBC Capital analyst Ashish Sabadra upgraded the rating to Outperform from Sector Perform.
Wells Fargo boosted the price target to $175 from $168, while maintaining an Overweight rating on the stock.
Barclays raised the price target to $165 from $160, while maintaining an Equal-Weight rating on the shares.
ECL in +1.58% Uptrend, advancing for three consecutive days on July 17, 2025
Moving higher for three straight days is viewed as a bullish sign. Keep an eye on this stock for future growth. Considering data from situations where ECL advanced for three days, in of 333 cases, the price rose further within the following month. The odds of a continued upward trend are .
Technical Analysis (Indicators)
Bullish Trend Analysis
The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. of 56 cases where ECL's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .
The Aroon Indicator entered an Uptrend today. In of 274 cases where ECL Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .
Bearish Trend Analysis
The Momentum Indicator moved below the 0 level on July 15, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on ECL as a result. In of 86 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .
The Moving Average Convergence Divergence Histogram (MACD) for ECL turned negative on July 09, 2025. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 52 similar instances when the indicator turned negative. In of the 52 cases the stock turned lower in the days that followed. This puts the odds of success at .
Following a 3-day decline, the stock is projected to fall further. Considering past instances where ECL declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .
The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating outstanding price growth. ECL’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 81, placing this stock slightly better than average.
The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (8.104) is normal, around the industry mean (3.653). P/E Ratio (47.585) is within average values for comparable stocks, (34.612). Projected Growth (PEG Ratio) (2.412) is also within normal values, averaging (6.312). Dividend Yield (0.010) settles around the average of (0.037) among similar stocks. P/S Ratio (4.263) is also within normal values, averaging (97.810).
Notable companies
Industry description
Market Cap
High and low price notable news
Volume
Fundamental Analysis Ratings
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Advertisement
General Information
a developer of cleaning, sanitizing, pest control, maintenance and repair products and services
Industry ChemicalsSpecialty
Advertisement